首页 | 本学科首页   官方微博 | 高级检索  
检索        


Fluorine‐18 labelling of a series of potential EGFRvIII targeting peptides with a parallel labelling approach using [18F]FPyME
Authors:Charlotte L Denholt  Bertrand Kuhnast  Frédéric Dollé  Francoise Hinnen  Paul R Hansen  Nic Gillings  Andreas Kjær
Institution:1. PET & Cyclotron Unit, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark;2. CEA, Institut d'imagerie biomédicale, Service hospitalier Frédéric Joliot, 91406 Orsay, France;3. Department of Natural Science, University of Copenhagen, 2100 Copenhagen, Denmark;4. Cluster for Molecular Imaging, University of Copenhagen, 2200 Copenhagen, Denmark
Abstract:There is growing interest in the use of radiolabelled peptides as receptor targeting agents for diagnostic imaging of various cancer types using positron emission tomography. In this work, 1‐3‐(2‐18F]fluoropyridin‐3‐yloxy)propyl]pyrrole‐2,5‐dione (18F]FPyME) has been used for parallel fluorine‐18 labelling of PEPHC1, a peptide selective towards the cancer‐specific mutation of the epidermal growth factor receptor (EGFRvIII), and a number of truncated and mutated analogues. Conjugation of the peptides with 18F]FPyME was achieved within 10 min in non‐decay‐corrected radiochemical yields of 30–50%. The high yield of the conjugation reaction combined with its short synthesis time allows the labelling of several peptides from a single batch of 18F]FPyME. Copyright © 2010 John Wiley & Sons, Ltd.
Keywords:targeting peptides  fluorine‐18 labelling  [18F]FPyME  EGFRvIII  cancer  PET
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号